Bloodstream infections in HIV-infected patients

References

• Paul S, Gilbert HM, Ziecheck W, Jacobs J, Sepkowitz KA. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. AIDS 1999; 13: 415-8; PMID:10199233; http://dx.doi.org/10.1097/00002030-199902250-00015
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD. HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27-34; PMID:16878047; http://dx.doi.org/10.1097/01.qai.0000233310.90484.16
   PubMed Web of Science ®Google Scholar
• Huson MA, Stolp SM, van der Poll T, Grobusch MP. Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review. Clin Infect Dis 2014; 58: 79-92; PMID:24046307; http://dx.doi.org/10.1093/cid/cit596
   PubMed Web of Science ®Google Scholar
• Mayanja BN, Todd J, Hughes P, Van der Paal L, Mugisha JO, Atuhumuza E, Tabuga P, Maher D, Grosskurth H. Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy. Trop Med Int Health 2010; 15: 697-705; PMID:20406428; http://dx.doi.org/10.1111/j.1365-3156.2010.02528.x
   PubMed Web of Science ®Google Scholar
• Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C. Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO8 APROCO-COPILOTE Study Group; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO3 AQUITAINE Study Group. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007; 46:72-7; PMID:17621240; http://dx.doi.org/10.1097/QAI.0b013e3181576818
   PubMed Web of Science ®Google Scholar
• Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord, Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, et al. CD4 cell count and the risk of AIDS or death inHIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med 2012; 9: 1001194; http://dx.doi.org/10.1371/journal.pmed.1001194
   PubMed Web of Science ®Google Scholar
• Zurlo JJ, Lane HC. AIDS: etiology, diagnosis, treatment and prevention. 4th ed. Philadelphia: Lippincott-Raven; 1997. Chapter 14.4, Other bacterial infections; p. 259-265
   Google Scholar
• Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, et al. Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD. The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis 2013; 57: 1038-47; PMID:23921881; http://dx.doi.org/10.1093/cid/cit423
   PubMed Web of Science ®Google Scholar
• INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015; 373: 795-807; PMID:26192873; http://dx.doi.org/10.1056/NEJMoa1506816
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Tacconelli E, Donati KG, Citton R, Leone F, Spanu T, Cauda R. HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr 2000; 23: 145-51; PMID:10737429; http://dx.doi.org/10.1097/0012-6334-200002010-00006
   PubMed Web of Science ®Google Scholar
• Afessa B, Morales I, Weaver B. Bacteremia in hospitalized patients with human immunodeficiency virus: A prospective, cohort study. BMC Infect Dis 2001; 1:13; PMID:11602019; http://dx.doi.org/10.1186/1471-2334-1-13
   PubMed Web of Science ®Google Scholar
• Chiang HH, Hung CC, Lee CM, Chen HY, Chen MY, Sheng WH, Hsieh SM, Sun HY, Ho CC, Yu CJ. Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care 2011; 15: 202; PMID:21345279; http://dx.doi.org/10.1186/cc10419
   PubMed Web of Science ®Google Scholar
• Rosenberg AL, Seneff MG, Atiyeh L, Wagner R, Bojanowski L, Zimmerman JE. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 2001; 29: 548-56; PMID:11373418; http://dx.doi.org/10.1097/00003246-200103000-00013
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41: 1-19
   PubMedGoogle Scholar
• PubMed Health [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2016 Feb 5]. Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/
   Google Scholar
• Pedersen RH, Lohse N, Østergaard L, Søgaard OS. The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review. HIV Med 2011; 12: 323-33; PMID:21059168; http://dx.doi.org/10.1111/j.1468-1293.2010.00892.x
   PubMed Web of Science ®Google Scholar
• Bliss SJ, O'Brien KL, Janoff EN, Cotton MF, Musoke P, Coovadia H, Levine OS. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 2008; 8: 67-80; PMID:17974480; http://dx.doi.org/10.1016/S1473-3099(07)70242-6
   PubMed Web of Science ®Google Scholar
• Harboe ZB, Larsen MV, Ladelund S, Kronborg G, Konradsen HB, Gerstoft J, Larsen C, Pedersen C, Pedersen G, Obel N, et al. Incidence and Risk Factors for Invasive Pneumococcal Disease in HIV-Infected and Non-HIV-Infected Individuals Before and After the Introduction of Combination Antiretroviral Therapy: Persistent High Risk Among HIV-Infected Injecting Drug Users. Clin Infect Dis 2014; 59: 1168-76; PMID:25038114; http://dx.doi.org/10.1093/cid/ciu558
   PubMed Web of Science ®Google Scholar
• Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F; Spanish Pneumococcal Infection Study Network (G03/103). Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005; 165: 1533-40; PMID:16009870; http://dx.doi.org/10.1001/archinte.165.13.1533
   PubMed Web of Science ®Google Scholar
• Silva JM Jr, dos Santos Sde S. Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics. J Int AIDS Soc 2013; 16: 17344; PMID:23374857; http://dx.doi.org/10.7448/IAS.16.1.17344
   PubMed Web of Science ®Google Scholar
• Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med. 2000; 132: 182-90; PMID:10651598; http://dx.doi.org/10.7326/0003-4819-132-3-200002010-00003
   PubMed Web of Science ®Google Scholar
• Sogaard OS, Lohse N, Gerstoft J, Kronborg G, Ostergaard L, Pedersen C, Pedersen G, Sørensen HT, Obel N. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis 2008; 47: 1345-53; PMID:18834317; http://dx.doi.org/10.1086/592692
   PubMed Web of Science ®Google Scholar
• Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992; 117: 314-24; PMID:1637028; http://dx.doi.org/10.7326/0003-4819-117-4-314
   PubMed Web of Science ®Google Scholar
• Gilks CF, Ojoo SA, Ojoo JC, Brindle RJ, Paul J, Batchelor BI, Kimari JN, Newnham R, Bwayo J, Plummer FA, et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 1996; 347: 718-23; PMID:8602001; http://dx.doi.org/10.1016/S0140-6736(96)90076-8
   PubMed Web of Science ®Google Scholar
• Hibbs JR, Douglas JM Jr, Judson FN, McGill WL, Rietmeijer CA, Janoff EN. Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994. Clin Infect Dis 1997; 25: 195-9; PMID:9332509; http://dx.doi.org/10.1086/514538
   PubMed Web of Science ®Google Scholar
• Gebo KA, Moore RD, Keruly JC, Chaisson RE. Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis 1996; 173: 857-62; PMID:8603963; http://dx.doi.org/10.1093/infdis/173.4.857
   PubMed Web of Science ®Google Scholar
• Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE; Adult and Adolescent Spectrum of HIV Disease Project. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis 2001; 32: 794-800; PMID:11229848; http://dx.doi.org/10.1086/319218
   PubMed Web of Science ®Google Scholar
• French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, et al. Twenty-three-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomized and placebo controlled trial. Lancet 2000; 355: 2106-11; PMID:10902624; http://dx.doi.org/10.1016/S0140-6736(00)02377-1
   PubMed Web of Science ®Google Scholar
• Archibald LK, Kazembe PN, Nwanyanwu O, Mwansambo C, Reller LB, Jarvis WR. Epidemiology of bloodstream infections in a bacille Calmette-Guérin-vaccinated pediatric population in Malawi. J Infect Dis 2003; 188: 202-8; PMID:12854074; http://dx.doi.org/10.1086/376507
   PubMed Web of Science ®Google Scholar
• Edge MD, Rimland D. Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. AIDS 1996; 10: 1635-9; PMID:8970683; http://dx.doi.org/10.1097/00002030-199612000-00007
   PubMed Web of Science ®Google Scholar
• Hung CC, Hsueh PR, Hsieh SM, Liu CJ, Chen MY, Luh KT. Bacteremia and fungemia in patients with advanced human immunodeficiency virus (HIV) infection in Taiwan. J Formos Med Assoc 1998; 97: 690-7; PMID:9830279
   PubMed Web of Science ®Google Scholar
• Mootsikapun P. Bacteremia in adult patients with acquired immunodeficiency syndrome in the northeast of Thailand. Int J Infect Dis 2007; 11: 226-31; PMID:16815065; http://dx.doi.org/10.1016/j.ijid.2006.02.010
   PubMed Web of Science ®Google Scholar
• Ortega M, Almela M, Soriano A, Marco F, Martínez JA, Muñoz A, Peñarroja G, Mensa J. Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality. Eur J Clin Microbiol Infect Dis 2008; 27: 969-76; PMID:18449581; http://dx.doi.org/10.1007/s10096-008-0531-5
   PubMed Web of Science ®Google Scholar
• Pedro-Botet ML, M∫dol JM, Vallés X, Romeu J, Sopena N, Giménez M, Tor J, Clotet B, Sabrià M. Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995-1997). Int J Infect Dis 2002; 6: 17-22; PMID:12044296; http://dx.doi.org/10.1016/S1201-9712(02)90130-X
   PubMedGoogle Scholar
• Phe T, Vlieghe E, Reid T, Harries AD, Lim K, Thai S, De Smet B, Veng C, Kham C, Ieng S, et al. Does HIV status affect the aetiology, bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia? Trop Med Int Health 2013; 18: 485-94; PMID:23294446; http://dx.doi.org/10.1111/tmi.12060
   PubMed Web of Science ®Google Scholar
• Stroud L, Srivastava P, Culver D, Bisno A, Rimland D, Simberkoff M, Elder H, Fierer J, Martone W, Gaynes R. Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995). Infect Control Hosp Epidemiol 1997; 18: 479-85; PMID:9247830; http://dx.doi.org/10.2307/30141187
   PubMed Web of Science ®Google Scholar
• Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008; 46: 787-94; PMID:18266611; http://dx.doi.org/10.1086/528716
   PubMed Web of Science ®Google Scholar
• Furuno JP, Johnson JK, Schweizer ML, Uche A, Stine OC, Shurland SM, Forrest GN. Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study. BMC Infect Dis 2011; 11: 298; PMID:22040268; http://dx.doi.org/10.1186/1471-2334-11-298
   PubMed Web of Science ®Google Scholar
• Burkey MD, Wilson LE, Moore RD, Lucas GM, Francis J, Gebo KA. The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med 2008; 9: 858-62; PMID:18754806
   PubMed Web of Science ®Google Scholar
• Kempker RR, Farley MM, Ladson JL, Satola S, Ray SM. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. J Infect 2010; 61: 372-81; PMID:20868707; http://dx.doi.org/10.1016/j.jinf.2010.09.021
   PubMed Web of Science ®Google Scholar
• Declercq S, De Munter P, Derdelinckx I, Verhaegen J, Peetermans WE, Vanderschueren S, Van Wijngaerden E. Characteristics, causes, and outcome of 54 episodes of bloodstream infections in a cohort of HIV patients. Infect Dis (Lond) 2015; 47: 611-7; PMID:25875395; http://dx.doi.org/10.3109/23744235.2015.1033002
   PubMed Web of Science ®Google Scholar
• Jacob ST, Pavlinac PB, Nakiyingi L, Banura P, Baeten JM, Morgan K, Magaret A, Manabe Y, Reynolds SJ, Liles WC, et al. Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score. PLoS One 2013; 8:e70305; PMID:23940557; http://dx.doi.org/10.1371/journal.pone.0070305
   PubMedGoogle Scholar
• Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001; 32: 263-9; PMID:11170916; http://dx.doi.org/10.1086/318457
   PubMed Web of Science ®Google Scholar
• Nadelman RB, Mathur-Wagh U, Yancovitz SR, Mildvan D. Salmonella bacteremia associated with the acquired immunodeficiency syndrome (AIDS). Arch Intern Med 1985; 145: 1968-71; PMID:3904653; http://dx.doi.org/10.1001/archinte.1985.00360110038010
   PubMedGoogle Scholar
• Celum CL, Chaisson RE, Rutherford GW, Barnhart JL, Echenberg DF. Incidence of salmonellosis in patients with AIDS. J Infect Dis 1987; 156: 998-1002; PMID:3680999; http://dx.doi.org/10.1093/infdis/156.6.998
   PubMed Web of Science ®Google Scholar
• Gruenewald R, Blum S, Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin Infect Dis 1994; 18: 358-63; PMID:8011816; http://dx.doi.org/10.1093/clinids/18.3.358
   PubMed Web of Science ®Google Scholar
• Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh AL, Corkill JE, Hart CA, Gilks CF, Molyneux ME. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002; 16: 1633-41; PMID:12172085; http://dx.doi.org/10.1097/00002030-200208160-00009
   PubMed Web of Science ®Google Scholar
• Gilks CF, Brindle RJ, Otieno LS, Simani PM, Newnham RS, Bhatt SM, Lule GN, Okelo GB, Watkins WM, Waiyaki PG, et al. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990; 336: 545-9; PMID:1975046; http://dx.doi.org/10.1016/0140-6736(90)92096-Z
   PubMed Web of Science ®Google Scholar
• Hung CC, Hung MN, Hsueh PR, Chang SY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Huang YT, Lo YC, et al. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance. Clin Infect Dis 2007; 45: 60-7; PMID:17554702; http://dx.doi.org/10.1086/520681
   PubMed Web of Science ®Google Scholar
• Peters RP, Zijlstra EE, Schijffelen MJ, Walsh AL, Joaki G, Kumwenda JJ, Kublin JG, Molyneux ME, Lewis DK. A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management. Trop Med Int Health 2004; 9: 928-34; PMID:15304000; http://dx.doi.org/10.1111/j.1365-3156.2004.01288.x
   PubMed Web of Science ®Google Scholar
• Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 417-32; PMID:20510282; http://dx.doi.org/10.1016/S1473-3099(10)70072-4
   PubMed Web of Science ®Google Scholar
• Meremo A, Mshana SE, Kidenya BR, Kabangila R, Peck R, Kataraihya JB. High prevalence of non-typhoid Salmonella bacteraemia among febrile HIV adult patients admitted at a tertiary hospital, north-western Tanzania. Int Arch Med 2012; 5: 28; PMID:23075077; http://dx.doi.org/10.1186/1755-7682-5-28
   PubMedGoogle Scholar
• Varma JK, McCarthy KD, Tasaneeyapan T, Monkongdee P, Kimerling ME, Buntheoun E, Sculier D, Keo C, Phanuphak P, Teeratakulpisarn N, et al. Bloodstream infections among HIV-infected outpatients, Southeast Asia. Emerg Infect Dis 2010; 16: 1569-75; PMID:20875282; http://dx.doi.org/10.3201/eid1610.091686
   PubMed Web of Science ®Google Scholar
• Kiertiburanakul S, Watcharatipagorn S, Chongtrakool P, Santanirand P. Epidemiology of bloodstream infections and predictive factors of mortality among HIV-infected adult patients in Thailand in the era of highly active antiretroviral therapy. Jpn J Infect Dis 2012; 65: 28-32; PMID:22274154
   PubMed Web of Science ®Google Scholar
• Petrosillo N, Viale P, Nicastri E, Arici C, Bombana E, Casella A, Cristini F, De Gennaro M, Dodi F, Gabbuti A, et al. Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis. 2002; 34: 677-85; PMID:11823956; http://dx.doi.org/10.1086/338813
   PubMed Web of Science ®Google Scholar
• Bedell RA, Anderson ST, van Lettow M, Akesson A, Corbett EL, Kumwenda M, Chan AK, Heyderman RS, Zachariah R, Harries AD, et al. High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi. PLoS One 2012; 7: 39347; http://dx.doi.org/10.1371/journal.pone.0039347
   Web of Science ®Google Scholar
• Lewis DK, Peters RP, Schijffelen MJ, Joaki GR, Walsh AL, Kublin JG, Kumwenda J, Kampondeni S, Molyneux ME, Zijlstra EE. Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre, Malawi. Int J Tuberc Lung Dis 2002; 6: 1067-74; PMID:12546114
   PubMed Web of Science ®Google Scholar
• Archibald LK, McDonald LC, Nwanyanwu O, Kazembe P, Dobbie H, Tokars J, Reller LB, Jarvis WR. A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis 2000; 181: 1414-20; PMID:10762572; http://dx.doi.org/10.1086/315367
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report: 2012 [internet]. World Health Organization, Geneva, Switzerland; 1997 [updated 2014; cited 2015 Aug 25]. Available from: http://www.who.intKiertiburanakul/tb/publications/global_report/en/
   Google Scholar
• Crump JA, Ramadhani HO, Morrissey AB, Saganda W, Mwako MS, Yang LY, Chow SC, Njau BN, Mushi GS, Maro VP, et al. Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study. Clin Infect Dis 2012; 55: 242-50; PMID:22511551; http://dx.doi.org/10.1093/cid/cis409
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America: Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. [internet] New York: Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America; 2015 [updated 2013 May 7; cited 2015 Aug 25]. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/Adult_OI.pdf
   Google Scholar
• Crump JA, Morrissey AB, Ramadhani HO, Njau BN, Maro VP, Reller LB. Controlled comparison of BacT/ALERT MB system, manual MYCO/F LYTIC, and ISOLATOR 10 system for detection of Mycobacterium tuberculosis bacteremia. J Clin Microbiol 2011; 49: 3054-7; PMID:21653761; http://dx.doi.org/10.1128/JCM.01035-11
   PubMed Web of Science ®Google Scholar
• Von Reyn CF. The signiflcanee of bacteremic tuberculosis among persons with HIV infection in developing countries. AIDS 1999; 13: 2193-5; PMID:10563704; http://dx.doi.org/10.1097/00002030-199911120-00001
   PubMed Web of Science ®Google Scholar
• Garbino J, Kolarova L, Lew D, Hirschel B, Rohner P. Fungemia in HIV-infected patients: a 12-year study in a tertiary care hospital. AIDS Patient Care STDS 2001; 15: 407-10; PMID:11522214; http://dx.doi.org/10.1089/108729101316914403
   PubMed Web of Science ®Google Scholar
• Hung CC, Chang SC. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J Antimicrob Chemother 2004; 54: 849-53; PMID:15456733; http://dx.doi.org/10.1093/jac/dkh438
   PubMed Web of Science ®Google Scholar
• Dromer F, Mathoulin-Pélissier S, Fontanet A, Ronin O, Dupont B, Lortholary O. French Cryptococcosis Study Group. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre-and post-HAART eras. AIDS 2004; 18: 555-62; PMID:15090810; http://dx.doi.org/10.1097/00002030-200402200-00024
   PubMed Web of Science ®Google Scholar
• Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, de Leon GP, Baughman W, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36:789-94; PMID:12627365; http://dx.doi.org/10.1086/368091
   PubMed Web of Science ®Google Scholar
• Michelet C, Arvieux C, François C, Besnier JM, Rogez JP, Breux JP, Souala F, Allavena C, Raffi F, Garre M, et al. Opportunistic infections occurring during highly active antiretroviral treatment. AIDS 1998; 12:1815-22; PMID:9792382; http://dx.doi.org/10.1097/00002-030-199814000-00013
   PubMed Web of Science ®Google Scholar
• Launay O, Lortholary O, Bouges-Michel C, Jarrouse B, Bentata M, Guillevin L. Candidemia: a nosocomial complication in Adults with late-stage AIDS. Clin Infect Dis 1998; 26:1134-41; PMID:9597242; http://dx.doi.org/10.1086/520291
   PubMed Web of Science ®Google Scholar
• Bertagnolio S, de Gaetano Donati K, Tacconelli E, et al. Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictoors of outcome. J chemother 2004; 16: 172-8; PMID:15216953; http://dx.doi.org/10.1179/joc.2004.16.2.172
   PubMed Web of Science ®Google Scholar
• Zheng J, Gui X, Cao Q, Yang R, Yan Y, Deng L, Lio J. A clinical study of acquired immunodeficiency syndrome associated Penicillium marneffei infection from a non-endemic area in China. PLoS One 2015; 10: 0130376
   Web of Science ®Google Scholar
• Filiotou A, Velegraki A, Giannaris M, Pirounaki M, Mitroussia A, Kaloterakis A, Archimandritis A. First case of Penicillium marneffei fungemia in Greece and strain susceptibility to five licensed systemic antifungal agents and posaconazole. Am J Med Sci 2006; 332: 43-5; PMID:16845242; http://dx.doi.org/10.1097/00000441-200607000-00009
   PubMed Web of Science ®Google Scholar
• López Moral L, Tiraboschi IN, Schijman M, Bianchi M, Guelfand L, Cataldi S, integrantes de la Red de Micología de la Ciudad de Buenos Aires. Fungemia in hospitals of the city of Buenos Aires, Argentina. Rev Iberoam Micol 2012; 29: 144-9; http://dx.doi.org/10.1016/j.riam.2011.11.001
   PubMed Web of Science ®Google Scholar
• McLeod DS, Mortimer RH, Perry-Keene DA, Allworth A, Woods ML, Perry-Keene J, McBride WJ, Coulter C, Robson JM. Histoplasmosis in Australia report of 16 cases and literature review. Medicine (Baltimore) 2011; 90:61-8; PMID:21200187; http://dx.doi.org/10.1097/MD.0b013e318206e499
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America: Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services [internet] New York: Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America; 2015 [updated January 28, 2016; cited 2016 Feb 5]. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
   Google Scholar